ASX - By Stock
|
RHY |
Re:
Ann: Dr David Atkins appointed Chief Executive Officer of Rhythm
|
|
Tobybreslin
|
9 |
3.5K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
9
|
3.5K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Novelna
|
|
Tobybreslin
|
5 |
2.0K |
0 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
Tobybreslin
|
91 |
30K |
1 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
91
|
30K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
Tobybreslin
|
91 |
30K |
0 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
91
|
30K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: 2024 EGM Notice of Meeting
|
|
Tobybreslin
|
91 |
30K |
4 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
91
|
30K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Receipt of Notice under Section 249D of the Corporations Act
|
|
Tobybreslin
|
11 |
5.7K |
2 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
11
|
5.7K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Receipt of Notice under Section 249D of the Corporations Act
|
|
Tobybreslin
|
11 |
5.7K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
11
|
5.7K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Receipt of Notice under Section 249D of the Corporations Act
|
|
Tobybreslin
|
11 |
5.7K |
5 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
11
|
5.7K
|
5
|
|
ASX - By Stock
|
GHY |
Re:
Ann: Suspension from Quotation
|
|
Tobybreslin
|
7 |
2.3K |
0 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
7
|
2.3K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Platform Expansion - Lung Cancer Diagnostic Test Update
|
|
Tobybreslin
|
17 |
8.1K |
1 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
17
|
8.1K
|
1
|
|
ASX - By Stock
|
DRE |
Re:
Ann: 16 Camp Scale Lithium Targets at Central Yilgarn & Mangaroon
|
|
Tobybreslin
|
47 |
24K |
7 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
47
|
24K
|
7
|
|
ASX - By Stock
|
DRE |
Re:
Ann: Further Ni-Cu-Co-3PGE Assays & Drilling to Recommence
|
|
Tobybreslin
|
23 |
13K |
3 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
23
|
13K
|
3
|
|
ASX - By Stock
|
DRE |
Dreadnought Resources’ directors increase company investment to $6.2m
|
|
Tobybreslin
|
0 |
392 |
8 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
0
|
392
|
8
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4C and Market Update
|
|
Tobybreslin
|
13 |
5.0K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
13
|
5.0K
|
3
|
|
ASX - By Stock
|
DRE |
Re:
Ann: Quarterly Activities Report - September 2023
|
|
Tobybreslin
|
11 |
4.2K |
5 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
11
|
4.2K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
TGA Blueprint
|
|
Tobybreslin
|
55 |
17K |
0 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
55
|
17K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
TGA Blueprint
|
|
Tobybreslin
|
55 |
17K |
0 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
55
|
17K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Amateurs
|
|
Tobybreslin
|
34 |
11K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
34
|
11K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Amateurs
|
|
Tobybreslin
|
34 |
11K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
34
|
11K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Amateurs
|
|
Tobybreslin
|
34 |
11K |
2 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
34
|
11K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: UK CA Mark granted for ColoSTAT
|
|
Tobybreslin
|
98 |
32K |
0 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
98
|
32K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: UK CA Mark granted for ColoSTAT
|
|
Tobybreslin
|
98 |
32K |
1 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
98
|
32K
|
1
|
|
ASX - By Stock
|
KTG |
Re:
Ann: Replacement Prospectus
|
|
Tobybreslin
|
8 |
4.5K |
0 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
8
|
4.5K
|
0
|
|
ASX - By Stock
|
DRE |
Re:
Ann: Additional Ironstones and Carbonatites Expanded
|
|
Tobybreslin
|
95 |
41K |
3 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
95
|
41K
|
3
|
|
ASX - By Stock
|
PLS |
Re:
lithium price in freefall!!!
|
|
Tobybreslin
|
102 |
54K |
0 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
102
|
54K
|
0
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Flames Well Records Second Highest IP24 in Woodford
|
|
Tobybreslin
|
80 |
28K |
6 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
80
|
28K
|
6
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Half Year Accounts
|
|
Tobybreslin
|
169 |
50K |
2 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
169
|
50K
|
2
|
|
ASX - By Stock
|
HIO |
Re:
Top 20 Shareholders
|
|
Tobybreslin
|
851 |
425K |
1 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
851
|
425K
|
1
|
|
ASX - By Stock
|
HIO |
Re:
Top 20 Shareholders
|
|
Tobybreslin
|
851 |
425K |
0 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
851
|
425K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Notification regarding unquoted securities - RHY
|
|
Tobybreslin
|
2 |
885 |
0 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
2
|
885
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Extends ColoSTAT Clinical Trial to Western Australia
|
|
Tobybreslin
|
34 |
13K |
0 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
34
|
13K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Study 7 clinical study
|
|
Tobybreslin
|
16 |
12K |
4 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
16
|
12K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Study 7 clinical study
|
|
Tobybreslin
|
16 |
12K |
0 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
16
|
12K
|
0
|
|